Recent crystallographic studies show that the T-cell receptor has a largely immunoglobulin-like structure and binds to MHC-peptide complexes through loops from paired V␣ and V␤ domains that focus on the central amino acids of the MHC-bound peptide, and to bacterial superantigens via peripheral aspects of the V␤ domain. The T-cell receptor is a multichain molecular complex with a binding specificity that allows it to sense structural variations among complexes between class I or class II MHC molecules and antigenic peptides, expressed on the surface of antigen-presenting cells. The specificity of the T-cell receptor lies in the clonally-restricted structure of the ␣␤ (or possibly ␥␦) chains, which form a combining site that recognizes a particular subset of peptide-MHC complexes. When a T-cell receptor recognizes its unique cognate peptide-MHC complex, the cell that bears it is activated through an intricate cascade of phosphorylation, molecular recruitment and second-messenger generation.
Since the first descriptions of genetic control of immune responsiveness in the early 1970s [1] [2] [3] , immunologists have followed a sinuous trail leading from phenomenology to mechanism. Following the initial success in determining high-resolution crystal structures of fragments of a Tcell receptor ␤ chain [4] and V␣ domain [5] , several laboratories have now reported structures of T-cell receptors alone or bound to antigen-presenting major histocompatibility complex (MHC) molecules or superantigens [6] [7] [8] . These structures offer a deeper understanding of the initial events that trigger T-cell activation, and should prompt the formulation of new hypotheses concerning signal transduction in T cells.
The T-cell receptor is a multichain molecular complex with a binding specificity that allows it to sense structural variations among complexes between class I or class II MHC molecules and antigenic peptides, expressed on the surface of antigen-presenting cells. The specificity of the T-cell receptor lies in the clonally-restricted structure of the ␣␤ (or possibly ␥␦) chains, which form a combining site that recognizes a particular subset of peptide-MHC complexes. When a T-cell receptor recognizes its unique cognate peptide-MHC complex, the cell that bears it is activated through an intricate cascade of phosphorylation, molecular recruitment and second-messenger generation. As a result of activation, the T cell produces soluble mediators, such as lymphokines, modulates the cell-surface expression of its receptor and accessory molecules, and controls a finely tuned immunological response that includes antibody production, attraction of inflammatory cells and direct effector functions.
A clone of T cells, characterized by a unique ␣␤ T-cell receptor, is generated by the somatic rearrangement of Tcell receptor ␣ and ␤ chain genes, along with the timed The domain structures of T-cell receptors and immunoglobulins. (a) A space-filling representation of the tight elbow bend between V␤ and C␤ of a T-cell receptor ␤ chain [4] . At the top, the CDR1 is green, CDR2 is violet, CDR3 is yellow and HV4 is red; the C␤ insertion is light The copyright holder has not given permission to reproduce this figure in an electronic format.
expression of coreceptor molecules CD4 or CD8, which define T cells that recognize class II or class I MHC molecules, respectively. This occurs in the thymus, where the cells are positively selected for expression of receptors with at least a low level of affinity for self MHC molecules, but also negatively selected to eliminate cells bearing receptors that have a high affinity for self MHC molecules. Although it has been particularly difficult to assess quantitatively the differences in affinity of T-cell receptors that determine the positive versus negative selection of the cells bearing them, measurements made in several different systems suggest that the window of affinity that allows this discrimination is narrow [9, 10] .
Once a particular clone of T cells has been established, the mature T cell is poised to identify foreign, dysregulated self or neo-tumor antigens on a class of cells generically termed antigen-presenting cells. Our accumulating knowledge of MHC and now T-cell receptor structure urges us to think of antigen-MHC complexes as minor structural variants on a major theme. These structural variations result from the selection of different peptides from the antigen-presenting cell by its class I or class II MHC molecules. Thus, via either the endogenous (class I) or endocytic (class II) pathway, MHC molecules first capture and then display peptides representative of the cell in which they are expressed or foreign antigens they encounter.
T-cell receptor structure
The three-dimensional structures of various T-cell receptor fragments and of several receptor-ligand complexes have now been determined by X-ray crystallography. The first structures to be determined were those of fragments: the extracellular portion of an isolated ␤ chain ( Fig. 1 ) [4] and an isolated V␣ domain [5] . More recently, the structure of the entire extracellular portion of a murine ␣␤ Tcell receptor has been revealed [6] . Further, views have been obtained of this T-cell receptor ( Fig. 2 ) [6] and of a human ␣␤ T-cell receptor [7] in ternary complexes with their cognate peptide-MHC complexes.
In addition to their cognate peptide-MHC complex, some T-cell receptors also bind tightly to the 'superantigens' produced by pathogenic bacteria such as Staphylococcus. Superantigens are so-called because of their ability to bind to whole classes of T-cell receptors, and thus elicit very powerful immune responses. To provide insight into this biologically curious and medically important phenomenon, the structure of the complex between a T-cell receptor ␤ chain and a superantigen has also been determined [8] . These structural analyses [4] [5] [6] [7] [8] confirm the general predictions based on amino-acid sequence and structural arguments [11] [12] [13] [14] as well as those based on mutational and functional evidence [15, 16] . The details of these predictions and models are now moot, as the new structures resolve issues of precise orientation and molecular contact. A backbone representation of a complex between a T-cell receptor and a peptide-MHC ligand [6] . The T-cell receptor (2C) is at the top and the peptide-MHC complex below (with the peptide in green; ␤2M refers to ␤2-microglobulin). In the T-cell receptor representation, V␣ CDR1 and CDR2 are magenta, V␣ HV4 is white, V␤ CDR1 and CDR2 are blue, V␤ HV4 is orange, and both CDR3s are green. (Reproduced with permission from [6] .)
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T-cell receptors resemble antibody constant domains, up to a point (see below), and the relative disposition of the constant and variable T-cell receptor modules is not unlike that found in antibody 'Fabs' (V L C L /V H C H 1 units).
The major loops connecting ␤ strands in the amino-terminal part of the molecule form the complementarity-determining regions (CDRs) which are disposed in essentially the same manner as that found in antibodies.
The T-cell receptor V␤ domain closely resembles an immunoglobulin variable domain (Fig. 1) ; it is more like a V L than a V H domain in the framework regions, and in the CDRs it has features found in both V L and V H domains. CDR loop length is a useful way to compare such structures. V␤ CDR1 is quite short -ten or eleven residues long [17] , comparable to the shortest V L CDR1. V␤ CDR2 is longer than V L CDR2, and is more similar to the V H CDR2. V␤ CDR3 is quite variable in length, ranging from eight to eighteen amino acids [17] , so V␤ more closely resembles V H in this region (though immunoglobulin light chains sometimes have a long CDR3). Interestingly, V␤ CDR3 is also similar to V H CDR3 in being encoded by D and J gene segments. The extra hypervariable region of V␤ (HV4) is intermediate in length between the corresponding V L and V H loops; it tucks in close to CDR1 and CDR2, more like the analogous region in V L (see Fig. 1 ).
The V␣ domain closely resembles V␤ (see Fig. 2 ) and is also more similar to a V L than a V H domain. In V␣, however, the bilayer ␤-sheet structure is slightly modified relative to V␤, V L and V H : a ␤ strand from one sheet is switched over to the other ␤ sheet. The V␣ CDR1 is on average shorter than the V L CDR1, ranging from ten to thirteen amino acids in length [17] ; the CDR2s are more variable in length and conformation. The V␣ CDR3 also shows length variation, ranging from nine to fifteen residues [17] . In the isolated V␣ structure [5] the CDR3 was disordered; in the complexes, however, the CDR3 loops were visible.
Turning to the constant regions, the T-cell receptor C␤ domain also closely resembles its immunoglobulin counterparts, though C␤ is differentiated by a large, solventexposed bulge. The bulge is produced by a thirteen or fourteen residue insert in the loop region connecting the last two ␤ strands of the domain. The bulges in the two murine ␤ chains, 2C [6] and 14.3.d [8] , have different loop conformations, suggestive of flexibility in this region of the molecule. The C␣ domain appears to be highly deformable.
In the 2C structure, the C␣ domain is characterized by high thermal factors, indicative of relatively high mobility; in the structure of the A6 T-cell receptor [7] , the C␣ domain is so disordered that it was left out of the refinement.
Although the 2C C␣ domain has the basic immunoglobulin fold [18] , there are large departures from a typical immunoglobulin C-type fold. The ␤ sheet that interacts with the opposite (C␤) domain is typical for a constant domain, but the other ␤ sheet is very different, with the ␤ strands too far apart to form the usual hydrogen-bonding pattern of an antiparallel ␤ sheet. The looser assembly of the C␣ ␤ sheet structure results in greater exposure to solvent of the interior hydrophobic residues. In C␣, the conserved tryptophan residue, which occurs 14 residues from the first cysteine of the intradomain disulfide bond in V␤ domains, is absent.
Structure of the complexes
Of greatest interest to immunologists, of course, is the nature of the interface between the T-cell receptor and the peptide-MHC complex, as we believe this should not only reveal how a given T-cell receptor discriminates between self and antigenic peptide-MHC complexes but also should shed light on the enigmatic phenomenon of antagonist peptides -peptides structurally similar to antigenic ones, but capable of delivering qualitatively distinct signals to the T cell. We now have structures of two T-cell receptor-peptide-MHC complexes: those of the receptor 2C bound to a complex between the murine MHC molecule H-2K b and peptide dEV8 [6] , determined at modest (Reproduced with permission from [6] .) (b) Shows the 'footprint' of the A6 T-cell receptor on the peptide-HLA-A2 molecular surface.
(Reproduced with permission from [7] .)
resolution with no refinement, and of receptor A6 bound to a complex between the human MHC molecule HLA-A2 and peptide Tax [7] , determined at high resolution with a reliable structure for the domains involved in the interface.
As illustrated in Figure 2 , the dimensions of the T-cell receptor and its relative orientation to its ligand clearly indicate that the CDRs make the primary binding interactions with the peptide-MHC complex. The T-cell receptor looks like an antibody Fab, and the interface with the peptide-MHC complex is of similar dimensions to that between antibodies and protein antigens [19] . The detailed orientation of V␣ over the amino-terminal half of the peptide and the 'left-hand' side of the ␣1 and ␣2 helices of the MHC molecule, and the way V␤ shadows the carboxyl-terminal half of the peptide and the 'righthand' side of the ␣1 and ␣2 helices, are the same for both T-cell receptor-peptide-MHC complexes [6, 7] , and strong arguments can be made [7] that this will be a canonical orientation for all ␣␤ T-cell receptor-MHC interactions.
Scrutiny of the regions of the peptide-MHC complex that are contacted by the CDRs and HV4 of V␣ and V␤ (Fig. 3 ) supports some predictions of the range of variation that different T-cell receptor-peptide-MHC complexes may encompass. Whereas the 2C T-cell receptor [6] interacts directly with the centre of the bound peptide in its peptide-H-2K b ligand through a relatively small area of its V␣ and V␤ CDR3s, the A6 T-cell receptor [7] exploits an extensive area of contact between V␤ CDR3 and its peptide-HLA-A2 ligand, with relatively little contribution from V␤ CDR2 and none from V␤ CDR1. The three V␣ CDRs of the A6 receptor make roughly equal contacts with the peptide-HLA-A2 complex. In the structure of the A6 complex, the Tax peptide was found to be embedded more deeply inside the HLA-A2 binding groove than in the isolated peptide-MHC complex, providing evidence for an 'induced fit' mechanism of receptor binding [7] .
Our knowledge of the scope of T-cell receptor interactions is further increased by the structure of the ␤ chain complexed with a bacterial superantigen [8] . A full picture of the receptor-superantigen interaction will require determination of a structure that includes the ␣ chain. Nevertheless, the structure has allowed Fields et al. [8] to propose a model that accounts for the ability of superantigens to bind ␤ chains alone, for the MHCdependence of the presentation of the low-affinity superantigens to T cells, and for the V␤-family restriction of some superantigens. The relatively weak interaction of the superantigen with V␤ CDR3 in this complex explains the lack of influence of particular peptides in the peptide-MHC complex on superantigen specificity.
A glimpse ahead
The new T-cell receptor structures have enhanced our knowledge of the kinds of interactions in which immunological cell-surface receptors can participate, and augur well for future studies. Questions of the dynamic nature of the surface events in T-cell activation remain, but we can feel confident that with the contemporary cooperation of molecular expression systems and X-ray crystallography the details of the static structure of ever more extensive T-cell activation complexes, in which the ␣␤ T-cell receptor, CD3 signalling complex, peptide-MHC ligand, coreceptor, and accessory and costimulatory molecules will be visualized.
